Souza Dos Santos Ana Celly, Soares Nayara Pereira, Costa Eduardo Caldas, de Sá Joceline Cássia Ferrezini, Azevedo George Dantas, Lemos Telma Maria Araújo Moura
Graduate Program in Pharmaceutical Sciences - CCS , Natal, RN , Brazil .
Gynecol Endocrinol. 2015 Mar;31(3):225-8. doi: 10.3109/09513590.2014.976546. Epub 2014 Nov 6.
To evaluate inflammatory markers and insulin resistance (IR) in women with and without polycystic ovary syndrome (PCOS), with different body mass index (BMI).
Tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and C-reactive protein (CRP) were assessed in serum samples from 40 women in reproductive age. Patients were divided into four groups: I (non-eutrophic with PCOS, n = 12), II (non-eutrophic without PCOS, n = 10), III (eutrophic with PCOS, n = 8) and IV (eutrophic without PCOS, n = 10) being non-eutrophic, the overweight and obese women with BMI > 25 kg/m2 and eutrophic women with BMI < 24.9 kg/m2. Homeostatic model assessment (HOMA-IR) was calculated for evaluation of IR.
PCOS patients showed increased levels of CRP (p < 0.01) and HOMA-IR (p < 0.01). When divided by BMI, both non-eutrophicad eutrophic PCOS showed increased CRP levels (p < 0.01) and HOMA-IR (p < 0.01). There were no differences in TNF-α and IL-6 levels between groups.
In the PCOS group, the levels of CRP and IR were elevated, compared to their counterparts, regardless of body mass.
评估不同体重指数(BMI)的多囊卵巢综合征(PCOS)女性和非PCOS女性的炎症标志物及胰岛素抵抗(IR)情况。
对40名育龄女性的血清样本进行肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和C反应蛋白(CRP)检测。患者被分为四组:I组(非肥胖型PCOS患者,n = 12),II组(非肥胖型非PCOS患者,n = 10),III组(肥胖型PCOS患者,n = 8)和IV组(肥胖型非PCOS患者,n = 10),其中BMI>25 kg/m²的女性为非肥胖型,BMI<24.9 kg/m²的女性为肥胖型。采用稳态模型评估法(HOMA-IR)计算IR以进行评估。
PCOS患者的CRP水平(p<0.01)和HOMA-IR(p<0.01)升高。按BMI分组时,非肥胖型和肥胖型PCOS患者的CRP水平(p<0.01)和HOMA-IR(p<0.01)均升高。各组之间TNF-α和IL-6水平无差异。
在PCOS组中,无论体重如何,与对照组相比,CRP水平和IR均升高。